Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (431-440 of 473) with videos related to

Pageof 48
Sort By:
Circulation|June 17, 2009
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studiesAjay J Kirtane, Anuj Gupta, Srinivas Iyengar, et al.
Circulation|April 7, 2005
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialAlexandra J Lansky, Cody Pietras, Ricardo A Costa, et al.
Journal of Thrombosis and Thrombolysis|October 19, 2010
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trialAdriano Caixeta, Gregg W Stone, Roxana Mehran, et al.
The American Journal of Cardiology|May 9, 2006
Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass graftsKoichi Sano, Gary S Mintz, Stéphane G Carlier, et al.
JACC. Cardiovascular Interventions|February 22, 2025
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisTayyab Shah, Zhiyuan Zhang, Haashim Shah, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
American Heart Journal|August 17, 2004
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen, Kenneth W Mahaffey, Richard C Becker, et al.
Circulation|February 3, 2005
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart AssociationAlexandra J Lansky, Judith S Hochman, Patricia A Ward, et al.
The Journal of Invasive Cardiology|November 8, 2007
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysisKoichi Sano, Gary S Mintz, Stephane G Carlier, et al.
The American Journal of Cardiology|August 28, 2007
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloonJose de Ribamar Costa, Gary S Mintz, Stéphane G Carlier, et al.
Pageof 48

Showing results (431-440 of 473) with videos related to

Sort By:
Pageof 48
Circulation|June 17, 2009
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studiesAjay J Kirtane, Anuj Gupta, Srinivas Iyengar, et al.
Circulation|April 7, 2005
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialAlexandra J Lansky, Cody Pietras, Ricardo A Costa, et al.
Journal of Thrombosis and Thrombolysis|October 19, 2010
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trialAdriano Caixeta, Gregg W Stone, Roxana Mehran, et al.
The American Journal of Cardiology|May 9, 2006
Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass graftsKoichi Sano, Gary S Mintz, Stéphane G Carlier, et al.
JACC. Cardiovascular Interventions|February 22, 2025
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisTayyab Shah, Zhiyuan Zhang, Haashim Shah, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
American Heart Journal|August 17, 2004
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen, Kenneth W Mahaffey, Richard C Becker, et al.
Circulation|February 3, 2005
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart AssociationAlexandra J Lansky, Judith S Hochman, Patricia A Ward, et al.
The Journal of Invasive Cardiology|November 8, 2007
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysisKoichi Sano, Gary S Mintz, Stephane G Carlier, et al.
The American Journal of Cardiology|August 28, 2007
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloonJose de Ribamar Costa, Gary S Mintz, Stéphane G Carlier, et al.
Pageof 48